Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs

Molecular Pharmacology

Volumn 55, Issue 6, 1999, Pages 1077-1087

  Quack, Marcus ^a   Carlberg, Carsten ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; RETINOID X RECEPTOR; SEOCALCITOL; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ARTICLE; BINDING AFFINITY; CONFORMATION; DIMERIZATION; DNA PROTEIN COMPLEX; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; MOLECULAR RECOGNITION; MOLECULAR STABILITY; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR SENSITIVITY;

EID: 0033016567     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.55.6.1077     Document Type: Article

References (38)

1. Bourguet W, Ruff M, Chambon P, Gronemeyer H and Moras D (1995) Crystal structure of the ligand binding domain of the human nuclear receptor RXR-α. Nature (Lond) 375:377-382.
2. 3: interplay with retinoid and thyroid hormone signalling. Eur J Biochem 231:517-527.
3. Carlberg C (1996a) The concept of multiple vitamin D pathways. J Invest Dermatol Symp Proc 1:10-14.
4. 3 receptor in the context of the nuclear receptor superfamily: The central role of retinoid X receptor. Endocrine 4:91-105.
5. 3 response elements, in Proceedings of the 10th International Vitamin D Workshop (Norman AW, Bouillon R and Thomasset M eds) pp 268-275, University of California, Printing and Reprographics, Riverside.
6. Carlberg C, Bendik I, Wyss A, Meier E, Sturzenbecker LJ, Grippo JF and Hunziker W (1993) Two nuclear signalling pathways for vitamin. D. Nature (Lond) 361:657-660.
7. 3 analogues MC903, EB1089 and KH1060 function as transcriptional activators: Vitamin D receptor homodimers show higher ligand sensitivity than heterodimers with retinoid X receptors. J Steroid Biochem Mol Biol 51:137-142.
8. 3. Crit Rev Eukaryot Gene Expr 8:19-42.
9. Colston KW, Mackay AG, James SY, Binderup L, Chander S and Coombes PC (1992) EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem Pharmacol 44:2273-2280.
10. 3 analogue is related to promoter selectivity. J Cell Biochem 66:552-562.
11. DeLuca HF, Krisinger J and Darwish H (1990) The vitamin D system: 1990. Kidney Int Suppl 29:S2-S8.
12. Gulliford T, English J, Colston KW, Menday P, Moller S and Coombes RC (1998) A phase I study of the vitamin D analogue EB1089 in patients with advanced breast and colorectal cancer. Br J Cancer 78:6-13.
13. Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS and Tung L (1996) Nuclear receptor coactivators and compressors. Mol Endocrinol 10:1167-1177.
14. 3 receptor identifying C-terminal amino acids required for transcriptional activation that are functionally dissociated from hormone binding, heterodimeric DNA binding, and interaction with basal transcription factor IIB, in vitro. J Biol Chem 272:14592-14599.
15. 3 receptor binding site found in the rat atrial natriuretic factor promoter. Biochem Biophys Res Commun 218:882-886.
16. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P and Evans RM (1995) The nuclear receptor superfamily: The second decade. Cell 83:835-839.
17. Masuyama H, Brownfield CM, St-Arnaud R and MacDonald PN (1997) Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Mol Endocrinol 11:1507-1517.
18. Mathiasen IS, Colston KW and Binderup L (1993) EB1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells. J Steroid Biochem Mol Biol 46:365-371.
19. Mørk Hansen C and Mäenpää PH (1997) EB1089 - a novel vitamin D analog with strong antiproliferative and differentiation inducing effects on target cells. Biochem Pharmacol 54:1173-1179.
20. Mørk Hansen C, Mathiasen IS and Binderup L (1996) The anti-proliferative and differentiation-inducing effects of vitamin D analogues are not determined by the binding affinity for the vitamin D receptor alone. J Invest Dermatol Symp Proc 1:44-48.
21. 3 receptor. Biochem J 235:561-568.
22. 3 analogues is not related to the AP-1 pathway, but related to promoter selectivity. Oncogene 11: 1853-1858.
23. 3 receptor is functionally linked to the transactivation domain 2 (AF-2) Nucleic Acids Res 24:4513-4619.
24. 3 correlates well with gene activation. J Cell Biochem 62:325-333.
25. 3 enhancement of mouse secreted phosphoprotein 1 (Spp-1 or osteopontin) gene expression. Proc Natl Acad Sci USA 87:9995-9999.
26. 3 and its A ring-modified analogs. Mol Endocrinol 12:525-535.
27. 3 are associated with enhanced activation of the vitamin D receptor. J Biol Chem 270:10551-10558.
28. 3 receptors: structure and function in transcription. Annu Rev Nutr 11:189-216.
29. Pols HAP, Birkenhäger JC and van Leeuven JPTM (1994) Vitamin D analogues: from molecule to clinical application. Clin Endocrinol 40:285-291.
30. Quack M, Clarin A, Binderup E, Björkling F, Mørk Hansen C and Carlberg C (1998a) Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity. J Cell Biochem 71:450-460.
31. 3 analogue EB1089 alters receptor complex formation and reduces promoter selectivity. Br J Pharmacol 125:607-614.
32. Renaud J-P, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H and Moras D (1995) Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature (Lond) 378:681-689.
33. Rhodes SJ, Chen R, DiMattia GE, Scully KM, Kalla KA, Lin S-C, Yu VC and Rosenfeld MG (1993) A tissue-specific enhancer confers Pit-1-dependent morphogen inducibility and autoregulation on the pit-1 gene. Genes Dev 7:913-932.
34. 3 response element identified in the mouse c-fos promoter. Biochem Biophys Res Commun 230:646-651.
35. 3 response elements formed by inverted palindromes: Polarity-directed ligand sensitivity of VDR-RXR heterodimer-mediated transactivation. Mol Cell Biol 15:1154-1161.
36. 3 analog KH1060. Proc Natl Acad Sci USA 93:10685-10690.
37. Vieth R (1990) The mechanisms of vitamin D toxicity. Bone Mineral 11:267-272.
38. Walters MR (1992) Newly identified actions of the vitamin D endocrine system. Endocr Rev 13:719-764.